NLS COVID-19

Research by an international consortium involving researchers at Karolinska Institutet shows that more than 10 percent of young and previously healthy people who develop severe COVID-19 have misguided antibodies that attack the immune system itself, and another 3.5 percent carry a specific genetic mutation. In both groups, the patients lack a set of proteins called […]

“We are holding our breath,” is how one company described the situation for the life science industry due to the economic effects of COVID-19. This was in April; now Autumn is coming and it looks as though it is going to be one long inhalation. We need to think about how to make the oxygen […]

SynAct Pharma has announced the initiation of a Phase II clinical study to evaluate the safety and efficacy of the company’s lead candidate drug AP1189 in adults diagnosed with COVID-19 and with early signs of Acute Respiratory Distress Syndrome (ARDS). The patients will be enrolled at medical centers in Brazil and in a collaboration between […]

In a new study published in JAMA researchers at Karolinska Institutet and Karolinska University Hospital have examined the association between a positive SARS-CoV-2 test during pregnancy and complications in mothers and their newborn babies. Almost two out of three pregnant women who tested positive for SARS-CoV-2 were asymptomatic and the researchers found no higher prevalence […]

The task of NordForsk is to facilitate research collaboration in the Nordic region, and within life sciences this is perhaps now more important than ever. The Nordic countries have handled the COVID-19 pandemic differently in many aspects and learning from each other would hopefully benefit our preparedness for another pandemic, or even a new wave […]

Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so. On 6 September, the standard review process triggered a voluntary pause to vaccination across all global trials to allow review of safety data by independent […]